MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026
Go back to MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026| (NASDAQ: MTVA) | Delayed: 1.74 -0.27 (13.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $ | |||
| Open | $1.88 | 52 Week Low | $ | |||
| Day High | $2.17 | P/E | N/A | |||
| Day Low | $1.72 | EPS | $ | |||
| Volume | 592,813 | |||||

